Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Managing Graves' orbitopathy].

George J Kahaly1

  • 1I. Med. Univ.-Klinik und Poliklinik Mainz. gkahaly@mail.uni-mainz.de

Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung
|July 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Euthyroidism and Long-Term Remission of Graves' Hyperthyroidism Following Treatment With an FcRn Blocker: A Case Report.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Secukinumab in Moderate-to-Severe Graves Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

The Journal of clinical endocrinology and metabolism·2025
Same author

Type 1 Diabetes and Other Autoimmune Diseases-Epidemiology, Pathophysiology and Screening.

Endocrinology, diabetes & metabolism·2025
Same author

Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy.

European thyroid journal·2025
Same author

Graves' disease in ectopic thyroid tissue: a scoping review and a case study.

European thyroid journal·2025
Same author

Unravelling the pathogenic mechanisms in Graves' orbitopathy.

European thyroid journal·2025

Graves' disease often causes inflammatory orbitopathy, marked by lymphocyte infiltration. While immunosuppressive therapy offers initial relief, surgical decompression is the most effective long-term treatment for thyroid eye disease.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Immunology

Context:

  • Thyroid orbitopathy, a common extrathyroidal manifestation of Graves' disease, involves lymphocyte infiltration into the peribulbar space.
  • Effective management requires an interdisciplinary approach for timely diagnosis and treatment.

Purpose:

  • To review the management strategies for inflammatory orbitopathy associated with Graves' disease.
  • To highlight the role of immunosuppressive therapy and surgical decompression in treating thyroid eye disease.

Summary:

  • Inflammatory orbitopathy is characterized by lymphocyte infiltration.
  • Initial treatment often involves immunosuppressive therapy, leading to subjective and objective improvements.
  • Surgical decompression is considered the most effective long-term treatment for thyroid eye disease.

Related Experiment Videos

Impact:

  • Provides insights into the optimal management of thyroid orbitopathy.
  • Emphasizes the long-term efficacy of surgical decompression over initial immunosuppressive treatments.
  • Aids clinicians in developing effective, interdisciplinary treatment plans for patients with Graves' ophthalmopathy.